Protherics PLC
Notification of Major Interest in Shares
London, UK; Brentwood, TN, US; 30 January 2007 - Protherics PLC ("Protherics" or
the "Company"), the international biopharmaceutical company focused on critical
care and cancer, announces that the following notification of interest in the
ordinary share capital of the Company was received on 29 January 2007 from Aviva
plc.
1. Reason for the notification (please tick the appropriate box or boxes)
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments which may result in the acquisition
of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):_________________________________
2. Full name of person(s) subject to the Aviva plc & its subsidiaries
notification obligation:
3. Full name of shareholder(s) (if different from Registered Holder:
2.):
BNY Norwich Union Nominees Limited
5,501,445*
Chase GA Group Nominees Limited
12,487,213*
Chase Nominees Limited
699,009*
CUIM Nominee Limited
4,905,449*
Vidacos Nominees Limited
86,079*
BNP Paribas - London
1,000,000
Chase Nominees Limited
675,775
CUIM Nominee Limited
3,550,079
State Street Nominees Limited
5,194,498
Vidacos Nominees Limited
5,741,350
*denotes direct interest
4. Date of the transaction (and date on which the 25 January 2007
threshold is crossed or reached if different):
5. Date on which issuer notified: 29 January 2007
6. Threshold(s) that is/are crossed or reached: 7% to 6% Change at Direct Interest level
7. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous to Resulting situation after the triggering transaction
shares the Triggering
transaction
if possible using Number of Number of Number of Number of voting rights % of voting
the ISIN CODE Shares Voting shares rights
Rights Direct Direct Indirect Direct Indirect
Ordinary Shares
GB0007029209 40,095,830 40,095,830 23,679,195 23,679,195 16,161,702 6.98% 4.77%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ Conversion Number of voting rights % of voting
instrument Period/ Date that may be acquired if rights
the instrument is
exercised/ converted.
N/A
Total (A+B)
Number of voting rights % of voting rights
39,840,897 11.75%
8. Chain of controlled undertakings through which the voting rights and/or the financial instruments are
effectively held, if applicable :
See Section 3
Proxy Voting:
9. Name of the proxy holder: See Section 3
10. Number of voting rights proxy holder will cease to hold:
11. Date on which proxy holder will cease to hold voting rights:
12. Additional information: Figures are based on a total number of voting rights of
338,976,174
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Anna Keeble +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
Protherics PLC announces Holding(s) in Company
| Source: Protherics PLC
Cheshire, UK -- (MARKET WIRE) -- January 30, 2007 --